Xiewan Chen

3.4k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Xiewan Chen is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiewan Chen has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiewan Chen's work include Cancer Immunotherapy and Biomarkers (6 papers), MicroRNA in disease regulation (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Xiewan Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), MicroRNA in disease regulation (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Xiewan Chen collaborates with scholars based in China, Australia and United States. Xiewan Chen's co-authors include Chenhui Wang, Ying Liu, Bo Diao, Yuzhang Wu, Zeqing Feng, Yi Zhang, Min Li, Yingjun Tan, Yongwen Chen and Yueping Liu and has published in prestigious journals such as Frontiers in Immunology, BioMed Research International and Oncotarget.

In The Last Decade

Xiewan Chen

22 papers receiving 2.1k citations

Hit Papers

Reduction and Functional Exhaustion of T Cells in Patient... 2020 2026 2022 2024 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
    2020 1.7k citations Bo Diao, Chenhui Wang et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiewan Chen China 11 1.4k 775 419 364 295 26 2.1k
Bo Diao China 15 1.9k 1.4× 1.0k 1.3× 501 1.2× 365 1.0× 456 1.5× 41 2.8k
Zeqing Feng China 11 1.8k 1.3× 948 1.2× 433 1.0× 299 0.8× 507 1.7× 17 2.6k
Jiawen Li China 13 976 0.7× 647 0.8× 253 0.6× 179 0.5× 334 1.1× 41 1.7k
Yan Xiong China 17 772 0.5× 409 0.5× 292 0.7× 372 1.0× 105 0.4× 74 1.6k
Chenhui Wang China 8 1.8k 1.3× 937 1.2× 360 0.9× 278 0.8× 372 1.3× 13 2.4k
Zilin Yuan China 7 1.7k 1.2× 911 1.2× 315 0.8× 265 0.7× 336 1.1× 11 2.2k
Gui-Qiang Wang United States 6 962 0.7× 581 0.7× 374 0.9× 185 0.5× 186 0.6× 7 1.5k
Hongling Wang China 20 606 0.4× 331 0.4× 482 1.2× 271 0.7× 152 0.5× 58 1.6k
Fengchun Zhang China 15 748 0.5× 407 0.5× 315 0.8× 139 0.4× 304 1.0× 63 1.7k

Countries citing papers authored by Xiewan Chen

Since Specialization
Citations

This map shows the geographic impact of Xiewan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiewan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiewan Chen more than expected).

Fields of papers citing papers by Xiewan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiewan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiewan Chen. The network helps show where Xiewan Chen may publish in the future.

Co-authorship network of co-authors of Xiewan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiewan Chen. A scholar is included among the top collaborators of Xiewan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiewan Chen. Xiewan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zheng, Linpeng, Feng-Lin Lin, Longyao Zhang, et al.. (2025). Single-cell transcriptome sequencing reveals the immune microenvironment in bronchoalveolar lavage fluid of checkpoint inhibitor-related pneumonitis. Cancer Immunology Immunotherapy. 74(4). 128–128.
3.
Zhang, Longyao, et al.. (2024). Characterization of zinc finger protein 536, a neuroendocrine regulator, using pan-cancer analysis. European journal of medical research. 29(1). 273–273.
4.
5.
Chen, Xu, et al.. (2024). High-resolution transcriptomics analysis of CXCL13+ EPSTI1+ CDK1+ cells with a specific focus on lung adenocarcinoma. Journal of Thoracic Disease. 16(1). 201–214. 3 indexed citations
6.
Chen, Xiewan, et al.. (2023). YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer. Canadian Respiratory Journal. 2023. 1–14. 2 indexed citations
7.
Li, Jixi, Linpeng Zheng, Chen Xu, et al.. (2022). Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer. Frontiers in Molecular Biosciences. 9. 786864–786864. 6 indexed citations
8.
Niu, Kaijun, Xiewan Chen, Yu Qin, et al.. (2021). Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study. Frontiers in Oncology. 11. 697227–697227. 10 indexed citations
9.
10.
Diao, Bo, Chenhui Wang, Yingjun Tan, et al.. (2020). Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Frontiers in Immunology. 11. 827–827. 1724 indexed citations breakdown →
11.
Zheng, Linpeng, Yanmei Wang, Zihan Xu, et al.. (2019). Concurrent EGFR-TKI and Thoracic Radiotherapy as First-Line Treatment for Stage IV Non-Small Cell Lung Cancer Harboring EGFR Active Mutations. The Oncologist. 24(8). 1031–e612. 62 indexed citations
12.
Chen, Xiewan, et al.. (2017). Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody. Oncology Letters. 14(1). 615–622. 7 indexed citations
13.
Zhao, Fengyi, Jing Han, Xiewan Chen, et al.. (2016). miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor. International Journal of Molecular Medicine. 38(1). 183–191. 35 indexed citations
14.
Diao, Xinwei, et al.. (2016). A case report: delayed high fever and maculopapules during Sorafenib treatment of ectopic hepatocellular carcinoma. BMC Cancer. 16(1). 543–543. 11 indexed citations
15.
Zhang, Li, Yang Yu, Xi Xia, et al.. (2016). Transcription factor E2-2 inhibits the proliferation of endothelial progenitor cells by suppressing autophagy. International Journal of Molecular Medicine. 37(5). 1254–1262. 6 indexed citations
16.
Xu, Yanmei, Xingyun Liao, Xiewan Chen, et al.. (2015). Regulation of miRNAs Affects Radiobiological Response of Lung Cancer Stem Cells. BioMed Research International. 2015. 1–7. 8 indexed citations
17.
Qiu, Jun, Xiewan Chen, Rongxia Liao, et al.. (2015). Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium. BMC Cancer. 15(1). 645–645. 34 indexed citations
18.
Sun, Jianguo, et al.. (2015). Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling. Oncotarget. 7(9). 9692–9706. 14 indexed citations
19.
20.
Chen, Xiewan, Rongxia Liao, & Min Chen. (2012). In‐career medical English training for doctors in China. Medical Education. 46(11). 1125–1126. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Diao Breakdown of academic impact, for papers by Zeqing Feng Breakdown of academic impact, for papers by Jiawen Li Breakdown of academic impact, for papers by Yan Xiong Breakdown of academic impact, for papers by Chenhui Wang Breakdown of academic impact, for papers by Zilin Yuan Breakdown of academic impact, for papers by Gui-Qiang Wang Breakdown of academic impact, for papers by Hongling Wang Breakdown of academic impact, for papers by Fengchun Zhang
Rankless by CCL
2026